Joseph Shulman Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Joseph Shulman is Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of RYTM, which is worth approximately $0. The most recent transaction as insider was on Nov 11, 2024, when has been sold 13,281 shares (Common Stock) at a price of $66.87 per share, resulting in proceeds of $888,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

0% 12M change

Total Value Held $0

Joseph Shulman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Open market or private sale	$888,100 $66.87 p/Share	13,281 Reduced 100.0%	0 Common Stock
Nov 11 2024	BUY Exercise of conversion of derivative security	$187,129 $14.09 p/Share	13,281 Added 50.0%	13,281 Common Stock
Jul 16 2024	SELL Open market or private sale	$554,804 $53.0 p/Share	10,468 Reduced 99.71%	30 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$286,299 $27.35 p/Share	10,468 Added 49.93%	10,498 Common Stock
Jul 12 2024	SELL Open market or private sale	$265,703 $50.01 p/Share	5,313 Reduced 99.44%	30 Common Stock
Jul 12 2024	BUY Exercise of conversion of derivative security	$113,591 $21.38 p/Share	5,313 Added 49.86%	5,343 Common Stock
May 09 2024	SELL Open market or private sale	$154,340 $38.74 p/Share	3,984 Reduced 99.25%	30 Common Stock
May 09 2024	BUY Exercise of conversion of derivative security	$27,091 $6.8 p/Share	3,984 Added 49.81%	4,014 Common Stock
Mar 21 2024	SELL Open market or private sale	$735,599 $40.34 p/Share	18,235 Reduced 99.84%	30 Common Stock
Mar 19 2024	SELL Open market or private sale	$608,498 $39.22 p/Share	15,515 Reduced 45.93%	18,265 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	33,750 Added 49.98%	33,780 Common Stock
Feb 14 2024	SELL Open market or private sale	$54,460 $50.01 p/Share	1,089 Reduced 97.32%	30 Common Stock
Feb 13 2024	SELL Open market or private sale	$93,250 $50.0 p/Share	1,865 Reduced 62.5%	1,119 Common Stock
Feb 13 2024	SELL Open market or private sale	$23,574 $49.84 p/Share	473 Reduced 13.68%	2,984 Common Stock
Feb 12 2024	SELL Open market or private sale	$40,641 $51.38 p/Share	791 Reduced 18.62%	3,457 Common Stock
Feb 11 2024	BUY Exercise of conversion of derivative security	-	1,562 Added 26.88%	4,248 Common Stock
Feb 09 2024	SELL Open market or private sale	$3,603,054 $50.2 p/Share	71,774 Reduced 96.39%	2,686 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	$1,536,067 $21.38 p/Share	71,846 Added 49.11%	74,460 Common Stock
Feb 01 2024	SELL Open market or private sale	$59,659 $45.06 p/Share	1,324 Reduced 33.62%	2,614 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	3,938 Added 50.0%	3,938 Common Stock
Dec 28 2023	SELL Open market or private sale	$396,300 $50.0 p/Share	7,926 Reduced 100.0%	0 Common Stock
Dec 28 2023	BUY Exercise of conversion of derivative security	$145,384 $21.38 p/Share	6,800 Added 46.18%	7,926 Common Stock
Dec 27 2023	SELL Open market or private sale	$250,800 $50.01 p/Share	5,015 Reduced 81.66%	1,126 Common Stock
Dec 27 2023	BUY Exercise of conversion of derivative security	$51,312 $21.38 p/Share	2,400 Added 28.1%	6,141 Common Stock
Nov 14 2023	SELL Open market or private sale	$894,432 $32.07 p/Share	27,890 Reduced 88.17%	3,741 Common Stock

Joseph Shulman

Chief Technical Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account